Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Deep anesthesia-Heidelberg University-shoulder surgery refers to a specific anesthetic protocol evaluated in a Phase 2 clinical trial (NCT00415896) conducted by Heidelberg University. This regimen involves the administration of high doses of propofol, fentanyl, and sevoflurane, specifically titrated to maintain a deep level of hypnosis as indicated by a Bispectral Index (BIS) value of 45 or lower. The study was designed to compare the physiological and immunological impacts of deep versus shallow anesthesia in patients undergoing shoulder surgery, focusing on changes in cerebrospinal fluid protein expression and the activity of immune cells such as T-cells and NK-cells. The protocol combines the GABA-A receptor modulating effects of propofol and sevoflurane with the analgesic properties of the mu-opioid receptor agonist fentanyl to achieve a profound state of general anesthesia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propofol + fentanyl + sevoflurane.